Brain dysfunction is a frequent complication of sepsis, usually defined as “sepsis-associated encephalopathy” (SAE). Its pathophysiology is complex and related to numerous processes and pathways, while the exact mechanisms pro- ducing neurological impairment in septic patients remain incompletely elucidated. Alterations of the cerebral blood flow (CBF) may represent a key component for the development of SAE. Reduction of CBF may be caused by cerebral vaso- constriction, either induced by inflammation or hypocapnia. Endothelial dysfunction associated with sepsis leads to im- pairment of microcirculation and cerebral metabolic uncoupling that may further reduce brain perfusion so that CBF be- comes inadequate to satisfy brain cellular needs. The natural autoregulatory mechanisms that protect the brain from re- duced/inadequate CBF can be impaired in septic patients, especially in those with shock or delirium, and this further con- tributes to cerebral ischemia if blood pressure drops below critical thresholds. Sedative agents alter cerebro-vascular reac- tivity and may significantly reduce CBF. Although disorders of brain perfusion and alteration of CBF and cerebral autoregulation are frequently observed in humans with sepsis, their exact role in the pathogenesis of SAE remains un- known. Brain perfusion can further become inadequate due to cerebral microcirculatory dysfunction, as evidenced in the experimental setting. Microvascular alterations can be implicated in the development of electrophysiological abnormali- ties observed during sepsis and contribute to neurological alterations in septic animals. The aim of this review is to pro- vide an update on the pathophysiology of brain perfusion in sepsis, with a particular focus on human clinical investigation and novel tools for CBF monitoring in septic patients.

Taccone, F.S., Scolletta, S., Franchi, F., Donadello, K., Oddo, M. (2013). Brain perfusion in sepsis. CURRENT VASCULAR PHARMACOLOGY, 11(2), 170-186 [10.2174/1570161111311020007].

Brain perfusion in sepsis.

SCOLLETTA, SABINO;FRANCHI, FEDERICO;
2013-01-01

Abstract

Brain dysfunction is a frequent complication of sepsis, usually defined as “sepsis-associated encephalopathy” (SAE). Its pathophysiology is complex and related to numerous processes and pathways, while the exact mechanisms pro- ducing neurological impairment in septic patients remain incompletely elucidated. Alterations of the cerebral blood flow (CBF) may represent a key component for the development of SAE. Reduction of CBF may be caused by cerebral vaso- constriction, either induced by inflammation or hypocapnia. Endothelial dysfunction associated with sepsis leads to im- pairment of microcirculation and cerebral metabolic uncoupling that may further reduce brain perfusion so that CBF be- comes inadequate to satisfy brain cellular needs. The natural autoregulatory mechanisms that protect the brain from re- duced/inadequate CBF can be impaired in septic patients, especially in those with shock or delirium, and this further con- tributes to cerebral ischemia if blood pressure drops below critical thresholds. Sedative agents alter cerebro-vascular reac- tivity and may significantly reduce CBF. Although disorders of brain perfusion and alteration of CBF and cerebral autoregulation are frequently observed in humans with sepsis, their exact role in the pathogenesis of SAE remains un- known. Brain perfusion can further become inadequate due to cerebral microcirculatory dysfunction, as evidenced in the experimental setting. Microvascular alterations can be implicated in the development of electrophysiological abnormali- ties observed during sepsis and contribute to neurological alterations in septic animals. The aim of this review is to pro- vide an update on the pathophysiology of brain perfusion in sepsis, with a particular focus on human clinical investigation and novel tools for CBF monitoring in septic patients.
2013
Taccone, F.S., Scolletta, S., Franchi, F., Donadello, K., Oddo, M. (2013). Brain perfusion in sepsis. CURRENT VASCULAR PHARMACOLOGY, 11(2), 170-186 [10.2174/1570161111311020007].
File in questo prodotto:
File Dimensione Formato  
3rd_Taccone_MS.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.24 MB
Formato Adobe PDF
1.24 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/42637
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo